Do you gain weight after stopping weight loss injections?

Weight regain after stopping GLP-1 medicines is well-documented in clinical trials and reflects the biology of obesity, not a lack of willpower.
The degree of regain varies widely between individuals and depends on how long treatment lasted, which medicine was used, and what lifestyle habits were maintained.
Stopping without a plan significantly increases the likelihood of regaining most of the weight lost during treatment.
A GPhC-registered prescriber should be involved in any decision to stop or pause, so that alternatives (including a structured stopping plan) can be considered.

Yes, most people do regain some weight after stopping weight loss injections. This is not a personal failure — it reflects how these medicines work. GLP-1 and dual-agonist treatments reduce appetite and slow gastric emptying while you take them; once the drug clears your system, those effects wear off and hunger returns. The question is not really whether some regain happens, but how much, how fast, and what can be done about it. These are prescription-only medicines, and decisions about stopping, continuing or switching are ones to make with a prescriber who knows your full history — not alone.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence says, and what it means for you

The myth: stopping means you keep the weight you lost

A question our prescribers hear most weeks goes something like this: "If I lose the weight I need to lose, can I just stop and stay there?" It is a completely understandable hope, and a reasonable one to examine carefully. The honest answer is that for most people, stopping the injection does not lock in the result.

The STEP 1 extension trial, published in the New England Journal of Medicine, followed participants who had completed 68 weeks of semaglutide treatment and then stopped. Within a year of stopping, they had regained around two-thirds of the weight they had lost. Appetite returned, energy intake increased, and the biological signals that had been quietened by the medicine came back. This is not unusual, it mirrors what happens after stopping most effective weight-loss treatments.

The reason is rooted in how obesity works as a condition. It involves persistent hormonal and neurological drivers that do not simply reset after a period of treatment. The NHS obesity overview describes obesity as a chronic condition with complex underlying causes, which is precisely why effective medicines for it tend to be long-term ones. Believing that a course of injections permanently rewires appetite is the biggest misconception to correct before making any decision about stopping.

What actually happens to appetite and weight when you stop

GLP-1 and dual-agonist medicines work by mimicking hormones that signal fullness and regulate how quickly food leaves the stomach. While the medicine is active, appetite is meaningfully suppressed and many people find they are satisfied with less food without needing to rely on willpower. Stop the injection, and within days to weeks those effects fade as the drug leaves the system.

For tirzepatide (the dual GIP and GLP-1 receptor agonist licensed in the UK as Mounjaro) the half-life means drug levels fall steadily over roughly five days after the last dose, with clinically meaningful effects largely gone within a few weeks. For semaglutide (Wegovy), the clearance is similar. There is no sudden dramatic reversal; hunger tends to creep back rather than surge. But creep back it does.

How quickly weight returns varies. People who have built consistent dietary habits and increased their physical activity during treatment tend to regain more slowly. Those who relied heavily on the medicine's appetite suppression without building those parallel habits often regain faster. That is not a moral judgement, it reflects the practical reality that lifestyle changes made alongside treatment act as a partial buffer once treatment stops. Our overview of weight loss injections covers how these medicines are designed to work alongside, not instead of, dietary and activity changes.

Do you gain weight back after stopping, is it inevitable?

Not entirely. Some people do maintain a portion of their weight loss, particularly those who used the treatment period to make lasting changes to eating patterns and activity levels. If you want a fuller picture of what the evidence shows, our page on whether you put weight back on after weight loss injections walks through the clinical data in detail. But the clinical evidence is clear that significant, sustained maintenance of the full amount lost is uncommon without continuing treatment of some kind.

This is one reason NICE's recommendation for tirzepatide, detailed in technology appraisal TA1026, includes a review at six months to assess whether treatment is delivering enough benefit to continue, the framework presumes ongoing use rather than a fixed course. The NICE recommendation for semaglutide similarly envisages treatment within specialist services rather than a short-term course followed by stopping.

If you are considering stopping because of side effects, cost, or a feeling that you have reached your goal, those are all worth discussing before making the call. There may be options worth exploring: a lower maintenance dose, a pause rather than a permanent stop, or a structured plan for what happens next. The detail of how to stop weight loss injections safely matters more than most people realise.

It is also worth being honest about what "stopping" means in practice. Some people stop intentionally; others stop because supply runs out, because cost becomes difficult, or because they feel well enough that treatment feels unnecessary. Each situation is different. What is consistent across them is that regain tends to follow, and that a planned stop (with prescriber input) gives you a better chance of holding onto more of what you gained.

Making a realistic plan before you stop

The most useful thing you can do before stopping is to speak to a prescriber, not after regain has already started. A prescriber can review your current dose, your goals, and your lifestyle changes so far, and help you think through the options. These options might include continuing at the lowest effective dose, transitioning to a different approach, or stopping with a clear plan for monitoring and support.

If you are thinking about your longer-term weight loss journey as a whole, treatment decisions sit within that broader picture rather than standing alone. Looking at weight loss injections before and after results from real patients can help ground your expectations in what is realistically achievable, both during treatment and once it stops. The goal of treatment is not just a number on the scales during the active phase, it is a sustainable position afterwards.

For those weighing up whether to continue or stop, the question of whether stopping is the right decision involves more clinical nuance than a simple yes or no. At nume, every repeat order is reviewed by a GPhC-registered Independent Prescriber before it is approved, the same clinical care applies whether you are asking about continuing or about stopping. If you would like that conversation, check your eligibility and start a free consultation, and if you are specifically using or considering tirzepatide, our guide to the Oz weight loss injection covers what to expect at each stage of treatment.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions